The article explores eight companies that are leveraging allogeneic cell therapy for cancer treatments, including A2 Biotherapeutics, Adicet Bio, Caribou Biosciences, Coeptis Therapeutics, Cytovia Therapeutics, IN8Bio, Poseida Therapeutics, and TC BioPharm. The global allogeneic cell therapy market, valued at $255.6 million in 2022, is expected to reach $1.72 billion by 2030, driven by advancements in gene editing and an increasing number of clinical trials.
Over 12m people to benefit from state pension increase tomorrow
More than 12 million people will see their state pension rise by £575 a year from tomorrow.
